Table 1.

Patients’ demographic and clinical characteristics

Patient	Age upon CAR T cell infusion	Gender	Diagnosis	Disease evaluation prior to CAR T cell infusion		Disease evaluation on day 28 post infusion
				BM	CNS	BM	CNS
1	54 years	Male	B-ALL	Positive	Negative	CRi, MRD negative	Negative
2	36 years	Female	B-ALL	Positive	Negative	CRi, MRD negative	Negative
3	48 years	Female	NHL, DLBCL	Negative	Positive	CRi, MRD negative	Stable disease

ALL = acute lymphocytic leukemia; NHL = non-Hodgkin lymphoma; DLBCL = diffuse large B-cell lymphoma; CSF = cerebrospinal fluid; CRi = complete remission with incomplete hematologic recovery; MRD = minimal residual disease